Zobrazeno 1 - 10
of 20
pro vyhledávání: '"P. L. Canner"'
Publikováno v:
International Journal of Clinical Practice. 67:297-302
Summary Background: This post hoc analysis from the Coronary Drug Project (CDP) evaluated the effects of niacin vs. placebo on the incidence of new onset type 2 diabetes mellitus (T2DM) and cardiovascular event rates in patients with normal and impai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79dc3a15c11c25e640e8e4bfeddfc5a0
https://doi.org/10.1111/ijcp.12089
https://doi.org/10.1111/ijcp.12089
Publikováno v:
International journal of clinical practice. 67(4)
This post hoc analysis from the Coronary Drug Project (CDP) evaluated the effects of niacin vs. placebo on the incidence of new onset type 2 diabetes mellitus (T2DM) and cardiovascular event rates in patients with normal and impaired fasting glucose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d37139342e2c4f040959b644f0dc45c2
https://pubmed.ncbi.nlm.nih.gov/23521321
https://pubmed.ncbi.nlm.nih.gov/23521321
Publikováno v:
Atherosclerosis Supplements. 11:160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184299e27982e71edaa954bc69c1929e
https://doi.org/10.1016/s1567-5688(10)70752-2
https://doi.org/10.1016/s1567-5688(10)70752-2
Publikováno v:
The New England journal of medicine. 325(25)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::612fa5a037254a328b7c6b24cf95163a
https://pubmed.ncbi.nlm.nih.gov/1834942
https://pubmed.ncbi.nlm.nih.gov/1834942
Autor:
K G, Berge, P L, Canner
Publikováno v:
European journal of clinical pharmacology. 40
Niacin was one of the treatments compared in the Coronary Drug Project, a placebo-controlled, multicenter trial of lipid-lowering drugs in the secondary prevention of coronary heart disease. A total of 1119 men, aged 30-64 at entry, were randomized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4640f9ea214454536e9610d973dd9bcb
https://pubmed.ncbi.nlm.nih.gov/2044644
https://pubmed.ncbi.nlm.nih.gov/2044644
Publikováno v:
New England Journal of Medicine. 325:1813-1814
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::721529cc0c9c72fcc08e6450ed529d29
https://doi.org/10.1056/nejm199112193252517
https://doi.org/10.1056/nejm199112193252517
Publikováno v:
Circulation. 66:401-414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4065f3a83c24f5ab34ff2ce55b4308
https://doi.org/10.1161/01.cir.66.2.401
https://doi.org/10.1161/01.cir.66.2.401
Autor:
P L Canner, M Halperin
Publikováno v:
Circulation. 63:1342-1350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92355fad63067b1bc5b57e312e1c86e2
https://doi.org/10.1161/01.cir.63.6.1342
https://doi.org/10.1161/01.cir.63.6.1342
Publikováno v:
Circulation. 66:1176-1178
The Coronary Drug Project was a randomized, placebo-controlled trial of lipid-influencing drugs in men who had recovered from one or more documented myocardial infarctions. Determinations of high-density lipoprotein (HDL) cholesterol were made at bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e79127e5ffcb2787cc2a229d06dc78
https://doi.org/10.1161/01.cir.66.6.1176
https://doi.org/10.1161/01.cir.66.6.1176
Publikováno v:
Controlled clinical trials. 4(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a17cf452783f095cd62b9472d925a8bc
https://pubmed.ncbi.nlm.nih.gov/6675895
https://pubmed.ncbi.nlm.nih.gov/6675895